Joel Plumas

Grenoble, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 46 publications

Irradiation-Induced CD62L Shedding in Human Plasmacytoid Dendritic Cells Depends on ADAM17 and p38 MAPK.

Irradiation-Induced CD62L Shedding in Human Plasmacytoid Dendritic Cells Depends on ADAM17 and p38 MAPK.

Journal: Immunology

Published: March 03, 2026

PD-1 blockade does not enhance alloimmunization after allogeneic dendritic cell vaccination in cancer patients.

PD-1 blockade does not enhance alloimmunization after allogeneic dendritic cell vaccination in cancer patients.

Journal: Frontiers in immunology

Published: December 08, 2025

Innovative therapeutic cancer vaccine PDC∗lung01 with or without anti-PD-1: an open-label, dose-escalation phase I/II study in non-small-cell lung cancer.

Innovative therapeutic cancer vaccine PDC∗lung01 with or without anti-PD-1: an open-label, dose-escalation phase I/II study in non-small-cell lung cancer.

Journal: ESMO open

Published: May 27, 2025

Identification of immunogenic HLA-A*02:01 epitopes associated with HCC for immunotherapy development.

Identification of immunogenic HLA-A*02:01 epitopes associated with HCC for immunotherapy development.

Journal: Hepatology communications

Published: November 04, 2024

Development of a New Off-the-Shelf Plasmacytoid Dendritic Cell-Based Approach for the Expansion and Characterization of SARS-CoV-2-Specific T Cells.

Development of a New Off-the-Shelf Plasmacytoid Dendritic Cell-Based Approach for the Expansion and Characterization of SARS-CoV-2-Specific T Cells.

Journal: Journal of immunology (Baltimore, Md. : 1950)

Published: October 27, 2023

A New Plasmacytoid Dendritic Cell-Based Vaccine in Combination with Anti-PD-1 Expands the Tumor-Specific CD8+ T Cells of Lung Cancer Patients.

A New Plasmacytoid Dendritic Cell-Based Vaccine in Combination with Anti-PD-1 Expands the Tumor-Specific CD8+ T Cells of Lung Cancer Patients.

Journal: International journal of molecular sciences

Published: November 30, 2022

Leveraging a powerful allogeneic dendritic cell line towards neoantigen-based cancer vaccines.

Leveraging a powerful allogeneic dendritic cell line towards neoantigen-based cancer vaccines.

Journal: Genes & cancer

Published: August 25, 2022

Harnessing dendritic cells for innovative therapeutic cancer vaccines.

Harnessing dendritic cells for innovative therapeutic cancer vaccines.

Journal: Current opinion in oncology

Published: December 21, 2021

Engineering a Human Plasmacytoid Dendritic Cell-Based Vaccine to Prime and Expand Multispecific Viral and Tumor Antigen-Specific T-Cells.

Engineering a Human Plasmacytoid Dendritic Cell-Based Vaccine to Prime and Expand Multispecific Viral and Tumor Antigen-Specific T-Cells.

Journal: Vaccines

Published: January 07, 2021

T-cell receptor diversity as a prognostic biomarker in melanoma patients.

T-cell receptor diversity as a prognostic biomarker in melanoma patients.

Journal: Pigment cell & melanoma research

Published: August 29, 2019

An innovative plasmacytoid dendritic cell line-based cancer vaccine primes and expands antitumor T-cells in melanoma patients in a first-in-human trial.

An innovative plasmacytoid dendritic cell line-based cancer vaccine primes and expands antitumor T-cells in melanoma patients in a first-in-human trial.

Journal: Oncoimmunology

Published: July 22, 2019

Photopheresis efficacy in the treatment of rheumatoid arthritis: a pre-clinical proof of concept.

Photopheresis efficacy in the treatment of rheumatoid arthritis: a pre-clinical proof of concept.

Journal: Journal of translational medicine

Published: April 10, 2019

Showing 1-12 of 46

Last Updated: 09/26/2026